SANA Diagnostics

Company Overview

Snapshot

Founded in April 2020 by Arnon Toussia Cohen, SANA Diagnostics operated with 1–10 employees. The company ceased operations in May 2022.

Business overview

SANA Diagnostics developed an algorithm leveraging artificial intelligence and signal processing for medical diagnostics through human voice analysis. The company's initial product focused on identifying obstructive sleep apnea (OSA), with plans to expand into diagnosing coronary artery disease, asthma, and potentially coronavirus infection. Operating in the Health Tech & Life Sciences sector, SANA Diagnostics aimed to serve both B2B and B2C markets within digital healthcare, specifically digital medical diagnostics.

Company Intelligence Q&A

What is SANA Diagnostics' primary focus?

SANA Diagnostics focuses on developing AI-based algorithms that analyze human voice patterns for medical diagnostic purposes.

When was SANA Diagnostics founded?

SANA Diagnostics was founded in April 2020.

What was the company's first product designed to diagnose?

The company's first product was designed to identify obstructive sleep apnea (OSA).

What technology underpins SANA Diagnostics' solutions?

SANA Diagnostics' solutions are built upon artificial intelligence and signal processing technologies to analyze voice data.

What is the current operational status of SANA Diagnostics?

SANA Diagnostics ceased operations in May 2022.